Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine.

Bianchini EP, Sebestyen A, Abache T, Bourti Y, Fontayne A, Richard V, Tamion F, Plantier JL, Doguet F, Borgel D

Open source

DOI
10.1111/bjh.15091
Published
2018 Mar
Container
British journal of haematology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.15091,
  title = {Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine.},
  author = {Bianchini EP and Sebestyen A and Abache T and Bourti Y and Fontayne A and Richard V and Tamion F and Plantier JL and Doguet F and Borgel D},
  year = {2018},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.15091},
  url = {https://doi.org/10.1111/bjh.15091}
}

RIS

TY  - JOUR
TI  - Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine.
AU  - Bianchini EP
AU  - Sebestyen A
AU  - Abache T
AU  - Bourti Y
AU  - Fontayne A
AU  - Richard V
AU  - Tamion F
AU  - Plantier JL
AU  - Doguet F
AU  - Borgel D
PY  - 2018
JO  - British journal of haematology
DO  - 10.1111/bjh.15091
UR  - https://doi.org/10.1111/bjh.15091
ER  - 

APA

EP, B., A, S., T, A., Y, B., A, F., V, R., F, T., JL, P., F, D., & D, B. (2018). Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine.. British journal of haematology. https://doi.org/10.1111/bjh.15091

Source records